Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

2014
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-31T18:43:22
publisher: Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis
label: RDF description of Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis - http://research.umh.es/vivo/pub/articulo/142290

Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis
type: Entity
most specific type: 2014
ARG_2000028: 142290 vcard
page end: 108
type: Generically Dependent Continuant
type: Anualidad
page start: 105
type: Continuant
type: Thing
related by: AutorExt:229526_2014-Artículo:142290
date time value: 142290 pubdate
type: Document
type: 2014
related by: AutorExt:229527_2014-Artículo:142290
type: Academic Article
type: Article
most specific type: Academic Article
related by: Autor:4585-Artículo:142290
has publication venue: REUMATOLOGIA CLINICA
type: Information Content Entity

AutorExt:229526_2014-Artículo:142290
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis

AutorExt:229527_2014-Artículo:142290
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis

Autor:4585-Artículo:142290
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis

REUMATOLOGIA CLINICA
type: Entity
publication venue for: Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis
type: Generically Dependent Continuant
type: Thing
type: Collection
type: Information Content Entity
type: Continuant
type: Journal
type: Periodical